ACDC (medicine)

ACDC (Arterial Calcification due to Deficiency of CD73), also known as Generalized Arterial Calcification of Infancy type 2 (GACI2), is a rare genetic disorder characterized by extensive vascular calcification early in life. This condition is caused by mutations in the NT5E gene, which encodes the enzyme CD73. This enzyme is crucial for producing adenosine, a molecule that plays a key role in preventing calcification within the arterial walls. The absence or malfunction of CD73 leads to reduced adenosine levels, resulting in widespread arterial calcification, cardiovascular disease, and potentially life-threatening complications.

Symptoms and Diagnosis[edit | edit source]

The primary symptom of ACDC is the extensive calcification of the arteries, which can lead to decreased blood flow and increased blood pressure. This can manifest in early childhood with symptoms such as irritability, feeding difficulties, failure to thrive, and severe respiratory distress. In some cases, symptoms may not appear until adulthood, presenting as leg pain during exercise due to poor blood circulation.

Diagnosis of ACDC is based on clinical examination, family history, and genetic testing for mutations in the NT5E gene. Imaging studies, such as X-rays, CT scans, and MRIs, are also used to detect arterial calcifications.

Treatment[edit | edit source]

There is no cure for ACDC, and treatment focuses on managing symptoms and preventing complications. This may include medications to control blood pressure, cholesterol levels, and to improve blood flow. In severe cases, surgical intervention may be necessary to bypass or remove calcified arteries. Additionally, lifestyle modifications, such as a healthy diet and regular exercise, are recommended to improve cardiovascular health.

Prognosis[edit | edit source]

The prognosis for individuals with ACDC varies depending on the severity of the condition and the effectiveness of the treatment. Early diagnosis and intervention can improve the quality of life and reduce the risk of life-threatening complications. However, individuals with ACDC require lifelong monitoring and care to manage their condition.

Epidemiology[edit | edit source]

ACDC is an extremely rare condition, with only a few documented cases worldwide. It affects males and females equally and can occur in any ethnic group.

Research[edit | edit source]

Research on ACDC is ongoing, with studies focusing on understanding the genetic mechanisms underlying the condition and developing targeted therapies. Gene therapy and drugs that can mimic the action of adenosine are among the potential treatments being explored.